The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Neutral 0

CooperCompanies Announces Release Date for Second Quarter 2026

AI-generated analysis

πŸ“… CooperCompanies announced it will release its second quarter 2026 financial results on Thursday, June 4, 2026.

πŸ• The earnings call is scheduled for 4:15 PM ET followed by a conference call at 5:00 PM ET.

πŸ“ž Investors can dial into the conference using number 800-715-9871 and conference ID 6529381.

🌐 A live webcast and subsequent replay of the call are available at www.investor.coopercos.com.

🏒 CooperCompanies operates as a leading global medical device company headquartered in San Ramon, CA.

πŸ‘₯ The company employs more than 15,000 people and sells products in over 130 countries.

πŸ’‘ Its portfolio positively impacts the lives of over fifty million people annually.

πŸ”¬ CooperCompanies consists of two main business units: CooperVision and CooperSurgical.

πŸ‘οΈ CooperVision is a trusted leader in the contact lens industry focused on improving daily vision.

πŸ‘©β€βš•οΈ CooperSurgical is a leading fertility and women's healthcare company dedicated to supporting families during critical moments.

πŸ“ˆ The Nasdaq ticker symbol for the company is COO.

🎯 Recent analyst activity includes a buy rating from Mizuho Securities and a hold rating from Morgan Stanley.

Bullish Signals
  • CooperCompanies, a leading global medical device company with over 15,000 employees, sells products in more than 130 countries and positively impacts over fifty million lives annually.
  • The company operates two trusted business units, CooperVision and CooperSurgical, which are dedicated to improving vision and women's fertility healthcare.
Risk Factors
  • A recent analyst downgrade by Citi lowered CooperCompanies' price target from $87 to $80, indicating bearish sentiment among investors.
  • Analyst outlook remains cautious with Morgan Stanley maintaining a Hold rating rather than upgrading the stock.
  • The release of upcoming Q2 2026 financial results on June 4, 2026, may reveal further weakness if trends persist.
Full Analysis
CooperCompanies, a leading global medical device company headquartered in San Ramon, California, announced today it will release its second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the publication of these results, the company will host a conference call to discuss the reported figures and current corporate developments at 5:00 PM ET. Investors and analysts can access simultaneous audio webcasts and replays of this discussion via the investor relations website at www.investor.coopercos.com or dial in using the number 800-715-9871 with conference ID 6529381. The San Ramon-based company operates two primary business units: CooperVision, a trusted leader in the contact lens industry, and CooperSurgical, a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at critical healthcare moments. With a global workforce exceeding 15,000 employees, CooperCompanies sells its products in over 130 countries and aims to positively impact more than fifty million lives annually through its mission to help people experience life's beautiful moments. This announcement serves as a standard corporate update regarding upcoming earnings reporting schedules rather than introducing new financial data or strategic changes. The press release notes that the editorial teams of Markets Insider and Business Insider were not involved in the creation of this post, ensuring the information is presented directly from the company via GlobeNewswire. While the article includes a section titled "Notable healthcare headlines for the week" listing various analyst actions such as Mizuho Securities' buy rating, Citi's price target reduction to $80, and Morgan Stanley's hold rating, these items are contextual additions rather than core details of CooperCompanies' immediate announcement.